Where is New Day Diagnostics located?

New Day Diagnostics is headquartered in Knoxville, United States.

Is New Day Diagnostics a funded company?

New Day Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does New Day Diagnostics rank among its competitors?

New Day Diagnostics ranks 482nd amongst 517 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Medicus Pharma, which secured $11M in May, 2024.

Who are the top competitors of New Day Diagnostics?

New Day Diagnostics' top competitors include PPD, Cambrian BioPharma and Kayentis. Among them, Medicus Pharma secured the most recent funding round in May, 2024.

New Day Diagnostics - 2026 Company Profile & Competitors

New Day Diagnostics is an unfunded company based in Knoxville (United States). It operates as a Provider of diagnostic testing, assay design, and clinical trial management. New Day Diagnostics has not raised any funding yet. The company has 517 active competitors, including 3 funded and 21 that have exited. Its top competitors include companies like PPD, Cambrian BioPharma and Kayentis.

Company Details

Provider of diagnostic testing, assay design, and clinical trial management. It offers services encompassing assay design, analytical validation, clinical performance evaluation, and regulatory compliance support. The company focuses on assisting partners in bringing diagnostic products to market, with specialized laboratories providing services across oncology, infectious diseases, gastrointestinal disorders, and women's health. It aims to advance personalized medicine through multiomic technologies and companion diagnostics, supporting clinical research with expertise in study design and data quality.

Key Metrics

Location

Knoxville, United States

Stage

Unfunded

Ranked

482^nd among 517 active competitors

Similar Companies

PPD & 518 more

View New Day Diagnostics' full profile

New Day Diagnostics has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of New Day Diagnostics include PPD, Cambrian BioPharma and Kayentis. Here is the list of Top 10 competitors of New Day Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PPD 1985, Wilmington (United States), Acquired	CRO providing diversified clinical development services	-	HHS	60/100
2nd	Cambrian BioPharma 2019, Brooklyn (United States), Series C	Developer of medicines and therapies	$211M	Apeiron Investment Group, Anthos Capital ... & 20 others	49/100
3rd	Kayentis 2003, Meylan (France), Series D	Provider of electronic clinical outcome assessment solutions for clinical trials	$36.2M	Extens, XAnge & 5 others	48/100
4th	H.U. Group Holdings 1950, Shinjuku (Japan), Public	Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.	-	-	42/100
5th	Symphony Health 2012, Horsham (United States), Acquired	Provider of clinical research, consulting, and commercial services for healthcare sectors	-	Autonomy Ventures, STG	42/100
6th	Medicus Pharma 2008, Toronto (Canada), Public	Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry	-	-	40/100
7th	Volv Global 2017, Epalinges (Switzerland), Funding Raised	Provider of AI and machine learning solutions for healthcare insights	-	Seedlink	37/100
8th	Across Global 2018, Durham (United States), Unfunded	Provider of clinical trial management services and data solutions globally	-	-	36/100
9th	Peachtree BioResearch Solutions 2008, Marietta (United States), Unfunded	Provider of clinical research services for biotechnology, pharmaceutical, and medical device companies	-	-	36/100
10th	Hangzhou Baicheng Pharmaceutical Technology 2011, Hangzhou (China), Public	Provider of comprehensive pharmaceutical research and development services across drug lifecycles	-	Paradise Silicon Valley Asset Management Group	35/100
482nd	New Day Diagnostics Knoxville (United States), Unfunded	Provider of diagnostic testing, assay design, and clinical trial management	-	-	16/100